ArticleCancer2020

Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.

Raffit Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.